Literature DB >> 17981610

Clinical significance of a novel single nucleotide polymorphism in the 5' untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.

Venkat R Katkoori1, Xu Jia, Chakrapani Chatla, Sanjay Kumar, Selvarangan Ponnazhagan, Tom Callens, Ludwine Messiaen, William E Grizzle, Upender Manne.   

Abstract

The recently identified human ortholog of the Rabphillin-3A-Like (RPH3AL) gene, located at the 17p13.3 locus, has been assessed for its mutational status and clinical significance in colorectal adenocarcinoma (CRC). Prospectively collected 95 frozen CRCs and their matching benign colonic epithelial tissues were evaluated for mutations and mRNA expression. Since, we observed a higher incidence of a single nucleotide polymorphism (SNP) at the -25 position in the 5'untranslated region (5'UTR-25) of RPH3AL, we performed the genotyping analysis of this SNP in a retrospective CRC cohort (n=134) to assess their clinical importance. Univariate and multivariate outcome analyses were performed. The cDNA analysis has detected point mutations in 6 CRCs, coding region SNPs in 14 CRCs, and non-coding region SNPs in 38 CRCs. Combined analyses of both cohorts has demonstrated that the incidence of SNP at 5'UTR-25 was 41% (95 of 229), and its A/A genotype (9%, 20 of 229) was observed exclusively in non-Hispanic Caucasians, and 19 of these cases were diagnosed with nodal metastasis. Patients who exhibited homozygous for A or C alleles had a significantly decreased levels of mRNA expression, increased risk of CRC recurrence and mortality. Therefore, these findings have significant clinical implications in assessing the aggressiveness of CRC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981610      PMCID: PMC2667692          DOI: 10.2741/2742

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  42 in total

1.  Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.

Authors:  J A Biegel; C D Burk; F G Barr; B S Emanuel
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

2.  Mutations of rabphillin-3A-like gene in colorectal cancers.

Authors:  Takanori Goi; Kazuo Takeuchi; Kanji Katayama; Kazuo Hirose; Akio Yamaguchi
Journal:  Oncol Rep       Date:  2002 Nov-Dec       Impact factor: 3.906

3.  Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas.

Authors:  I Wieland; K C Arden; D Michels; L Klein-Hitpass; M Böhm; C S Viars; U H Weidle
Journal:  Oncogene       Date:  1999-08-12       Impact factor: 9.867

4.  Multiple genetic alterations in distal and proximal colorectal cancer.

Authors:  O Delattre; S Olschwang; D J Law; T Melot; Y Remvikos; R J Salmon; X Sastre; P Validire; A P Feinberg; G Thomas
Journal:  Lancet       Date:  1989-08-12       Impact factor: 79.321

5.  A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.

Authors:  Hongbing Shen; Luo Wang; Margaret R Spitz; Waun K Hong; Li Mao; Qingyi Wei
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

6.  Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

Authors:  Scott D Cramer; Bao-Li Chang; Anuradha Rao; Gregory A Hawkins; S Lilly Zheng; Wendy N Wade; Roger T Cooke; Leanne N Thomas; Eugene R Bleecker; William J Catalona; David A Sterling; Deborah A Meyers; Jill Ohar; Jianfeng Xu
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

7.  Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer.

Authors:  J M Garcia; R Rodriguez; G Dominguez; J M Silva; M Provencio; J Silva; A Colmenarejo; I Millan; C Muñoz; C Salas; S Coca; P España; F Bonilla
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

8.  Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.

Authors:  Mehmet Gunduz; Mamoru Ouchida; Kunihiro Fukushima; Sachio Ito; Yoshimi Jitsumori; Tomoko Nakashima; Noriyuki Nagai; Kazunori Nishizaki; Kenji Shimizu
Journal:  Oncogene       Date:  2002-06-27       Impact factor: 9.867

Review 9.  Role of genetic polymorphisms in tumour angiogenesis.

Authors:  S P Balasubramanian; N J Brown; M W R Reed
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

10.  Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity.

Authors:  Kazuyuki Kawakami; Yoshinori Ishida; Kathleen D Danenberg; Kenji Omura; Go Watanabe; Peter V Danenberg
Journal:  Jpn J Cancer Res       Date:  2002-11
View more
  4 in total

Review 1.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

2.  A novel 5'-uncoding region -1248 A>G variation of mitofusin-2 gene is associated with hypertension in Chinese.

Authors:  Zuoguang Wang; Ya Liu; Jieling Liu; Qiuli Niu; Jie Wen; Shaojun Wen; Zhaosu Wu
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

3.  Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.

Authors:  Venkat R Katkoori; Chandrakumar Shanmugam; Xu Jia; Swaroop P Vitta; Meenakshi Sthanam; Tom Callens; Ludwine Messiaen; Dongquan Chen; Bin Zhang; Harvey L Bumpers; Temesgen Samuel; Upender Manne
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

4.  Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.

Authors:  Balananda-Dhurjati Kumar Putcha; Xu Jia; Venkat Rao Katkoori; Chura Salih; Chandrakumar Shanmugam; Trafina Jadhav; Liselle C Bovell; Michael P Behring; Tom Callens; Ludwine Messiaen; Sejong Bae; William E Grizzle; Karan P Singh; Upender Manne
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.